Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-967-7 | CAS number: 3296-90-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and appropriate guidelines
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- study was done before requirements were known
Test material
- Reference substance name:
- 2,2-bis(bromomethyl)propane-1,3-diol
- EC Number:
- 221-967-7
- EC Name:
- 2,2-bis(bromomethyl)propane-1,3-diol
- Cas Number:
- 3296-90-0
- Molecular formula:
- C5H10Br2O2
- IUPAC Name:
- 2,2-bis(bromomethyl)propane-1,3-diol
- Details on test material:
- White crystalline solid
Storage conditions : room temperature in the dark
Purity : 99.34%
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- Weight range of 300 to 450g, eight to twelve weeks old.
The animals were housed singly or in pairs in solid-floor polypropylene cages furnished with
woodflakes with free access to mains tap water and food.
The temperature and relative humidity were set to achieve limits of 17 to 23°C and 30 to 70%
respectively. The rate of air exchange was at least fifteen changes per
hour and the lighting was controlled by a time switch to give twelve hours continuous light (06:00
to 18:00) and twelve hours darkness.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- arachis oil
- Concentration / amount:
- For intradermal induction: 5% w/w in arachis oil BP.
For topical induction: 75%, 50%, 25% and 10% w/w in arachis oil BP.
For topical Challenge: 75%, 50%, 25% and 10% w/w in arachis oil BP
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- arachis oil
- Concentration / amount:
- For intradermal induction: 5% w/w in arachis oil BP.
For topical induction: 75%, 50%, 25% and 10% w/w in arachis oil BP.
For topical Challenge: 75%, 50%, 25% and 10% w/w in arachis oil BP
- No. of animals per dose:
- Intradermal Induction: One guinea pig.
Topical induction: Two guinea pigs.
Topical Challenge: Two guinea pigs.
Main study: A group of fifteen guinea pigs was used for the main study, ten test and five control. - Details on study design:
- Selection of concentrations for main study:
Selection of concentration for Intradermal study: Intradermal injections (0.1ml/injection site) were made on the clipped shoulder of one guinea pig, at a concentration of 5% w/w in arachis oil BP. The degree of erythema at the injection sites was assessed approx. 24, 48, 72 and 7 days after injection.
Selection of concentration for tropical induction: Two guinea pigs (intradermally injected with Freund's Adjuvant seven days earlier) were treated with four preparations of the test material (75%, 50%, 25% and 10% w/w in arachis oil BP). Applications were made to the clipped flanks under occlusive dressings for an exposure period of 48 hr. The degree of erythema and oedema was evaluated approx. 1, 24 and 48 hr after dressing removal. The highest concentration producing only mild to moderate dermal irritation was selected for the topical induction stage of the main study.
Selection of concentration for topical challenge: Four preparations of the test material (75%, 50%, 25% and 10% w/w in arachis oil BP) were applied to the clipped flanks of two guinea pigs under occlusive dressings for an exposure period of 24 hr. These guinea pigs did not form part of the main study but had been treated identically to the control animals of the main study, up to day 14. The degree of erythema and oedema was evaluated approx. 1, 24 and 48 hr after dressing removal.The highest non-irritant concentration of the test material and one lower concentration were selected for the topical challenge stage of the main study.
Main study:
group of fifteen guinea pigs was used for the main study, ten test and five control.
Two phases were involved in the main study (a) an induction of the response and (b) a challenge of that response
Induction:
Induction of test animals:
Test animals were injected with Freunds complete adjuvant plus distilled water in the ratioo 1:1; a 5% w/w formulation of the test material in arachis oil BP; a 5% w/w formulation of the test material in a 1:1 preparation of Freunds complete adjuvant pus distilled water.
Approx. 24 and 48 hr after injection the degree of erythema at the test injection sites were evaluated.
On day 7 the same area used for intradermal injections was clipped and treated with topical application of the test material formulation. The occlusive dressing was kept in place for 48 hr. The degree of erythema and oedema was quantified one and 24 hr following removal of the patches .
induction of control animals: The intradermal induction was performed using identical procedure to that used for the test animals except that the test material was omitted from the intradermal injections. Similarly, the topical induction procedure was identical to that used for the test animals except that the test material was omitted.
Challenge:
Shortly before treatment on day 21 a square filter paper patch loaded with the test material formulation at the maximum non-irritant concentration (75% w/w in arachis oil BP) was applied to the shorn right flank of each animal and was held in place with a strip of surgical adhesive tape. To ensure that maximum non-irritant concentration was used at challenge, the test material at a concentration of 50% w/w in arachis oil BP was similarly applied to a skin site on the left shorn flank. After 24 hr, the dressing was removed and discarded. Appox. 24 and 48 hr after challenge removal, the degree of erythema and oedema was quantified.
- Challenge controls:
- non
- Positive control substance(s):
- yes
- Remarks:
- 2-MERCAPTOBENZOTHIAZOLE
Results and discussion
- Positive control results:
- 2-MERCAPTOBENZOTHIAZOLE produced a 80% (8/10) sensitisation rate (see attacment)
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 75% w/w
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Moderate and confluent erythema was noted at the intradermal induction sites
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50% and 75%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Discrete or patchy to moderate and confluent erythema was noted at the intradermal induction sites of control group animals
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 50 and 25%
- No. with + reactions:
- 8
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- strong sensitizer to guinea pigs skin
Any other information on results incl. tables
Skin Reactions Observed After Intradermal Induction:
Moderate and confluent erythema was noted at the intradermal induction sites of test group
animals.
Discrete or patchy to moderate and confluent erythema was noted at the intradermal induction
sites of control group animals.
Skin Reactions Observed After Topical Induction:
Discrete or patchy to moderate and confluent erythema with or without very slight to slight
oedema was noted at the topical induction sites of test group animals.
Discrete or patchy to moderate and confluent erythema was noted at the topical induction sites of
control group animals.
Bleeding from the intradermal injection sites was noted in eight test group animals and one
control group animal.
Skin Reactions Observed After Topical Challenge:
75% w/w in Arachis Oil BP:
No skin reactions were noted at the challenge sites of the test or control group animals at the 24 or
48-hour observations.
50% w/w in Arachis Oil BP:
No skin reactions were noted at the challenge sites of the test or control group animals at the 24 or
48-hour observations.
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of the test, the test material produced a 0% (0/10) sensitisation
rate and was classified as a non-sensitiser to guinea pig skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.